The Role of Pembrolizumab in the Treatment of Sebaceous Carcinoma.
Int Ophthalmol Clin
; 60(2): 39-46, 2020.
Article
in En
| MEDLINE
| ID: mdl-32205651
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sebaceous Gland Neoplasms
/
Adenocarcinoma, Sebaceous
/
Antibodies, Monoclonal, Humanized
Limits:
Humans
Language:
En
Journal:
Int Ophthalmol Clin
Year:
2020
Document type:
Article
Country of publication:
Estados Unidos